instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the outcome of reaction 'Ventricular extrasystoles'? | Plasma concentration of amitriptyline and metabolites after resuscitation from cardiopulmonary arrest following an overdose: A case report.
It may need to pay attention to the sustention of moderate cardiotoxicity and delayed elevation of plasma 10-hydroxynortriptyline level in severe amitriptyline overdose case.
1 INT... | Not recovered | ReactionOutcome | CC BY-NC-ND | 33598249 | 18,711,570 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug reaction with eosinophilia and systemic symptoms'. | Chronic persistent HHV-6B infection after sulfasalazine-induced DRESS with demonstration of HHV-6 encoded small noncoding RNAs (sncRNAs) in Crohn's-like colitis: Case report.
A sulfasalazine-induced DRESS (Drug Reactivation with Eosinophilia and Systemic Symptoms) was complicated by a Crohn's-like colitis. We demonstra... | SULFASALAZINE | DrugsGivenReaction | CC BY-NC-ND | 33598255 | 18,874,347 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Face oedema'. | Chronic persistent HHV-6B infection after sulfasalazine-induced DRESS with demonstration of HHV-6 encoded small noncoding RNAs (sncRNAs) in Crohn's-like colitis: Case report.
A sulfasalazine-induced DRESS (Drug Reactivation with Eosinophilia and Systemic Symptoms) was complicated by a Crohn's-like colitis. We demonstra... | SULFASALAZINE | DrugsGivenReaction | CC BY-NC-ND | 33598255 | 18,874,347 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatitis'. | Chronic persistent HHV-6B infection after sulfasalazine-induced DRESS with demonstration of HHV-6 encoded small noncoding RNAs (sncRNAs) in Crohn's-like colitis: Case report.
A sulfasalazine-induced DRESS (Drug Reactivation with Eosinophilia and Systemic Symptoms) was complicated by a Crohn's-like colitis. We demonstra... | SULFASALAZINE | DrugsGivenReaction | CC BY-NC-ND | 33598255 | 18,874,347 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Human herpesvirus 6 infection reactivation'. | Chronic persistent HHV-6B infection after sulfasalazine-induced DRESS with demonstration of HHV-6 encoded small noncoding RNAs (sncRNAs) in Crohn's-like colitis: Case report.
A sulfasalazine-induced DRESS (Drug Reactivation with Eosinophilia and Systemic Symptoms) was complicated by a Crohn's-like colitis. We demonstra... | SULFASALAZINE | DrugsGivenReaction | CC BY-NC-ND | 33598255 | 20,563,226 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Mononucleosis syndrome'. | Chronic persistent HHV-6B infection after sulfasalazine-induced DRESS with demonstration of HHV-6 encoded small noncoding RNAs (sncRNAs) in Crohn's-like colitis: Case report.
A sulfasalazine-induced DRESS (Drug Reactivation with Eosinophilia and Systemic Symptoms) was complicated by a Crohn's-like colitis. We demonstra... | SULFASALAZINE | DrugsGivenReaction | CC BY-NC-ND | 33598255 | 18,874,347 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonitis'. | Chronic persistent HHV-6B infection after sulfasalazine-induced DRESS with demonstration of HHV-6 encoded small noncoding RNAs (sncRNAs) in Crohn's-like colitis: Case report.
A sulfasalazine-induced DRESS (Drug Reactivation with Eosinophilia and Systemic Symptoms) was complicated by a Crohn's-like colitis. We demonstra... | SULFASALAZINE | DrugsGivenReaction | CC BY-NC-ND | 33598255 | 18,874,347 | 2021-02 |
What was the administration route of drug 'SULFASALAZINE'? | Chronic persistent HHV-6B infection after sulfasalazine-induced DRESS with demonstration of HHV-6 encoded small noncoding RNAs (sncRNAs) in Crohn's-like colitis: Case report.
A sulfasalazine-induced DRESS (Drug Reactivation with Eosinophilia and Systemic Symptoms) was complicated by a Crohn's-like colitis. We demonstra... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33598255 | 20,563,226 | 2021-02 |
What was the outcome of reaction 'Drug reaction with eosinophilia and systemic symptoms'? | Chronic persistent HHV-6B infection after sulfasalazine-induced DRESS with demonstration of HHV-6 encoded small noncoding RNAs (sncRNAs) in Crohn's-like colitis: Case report.
A sulfasalazine-induced DRESS (Drug Reactivation with Eosinophilia and Systemic Symptoms) was complicated by a Crohn's-like colitis. We demonstra... | Recovered | ReactionOutcome | CC BY-NC-ND | 33598255 | 18,874,347 | 2021-02 |
What was the outcome of reaction 'Face oedema'? | Chronic persistent HHV-6B infection after sulfasalazine-induced DRESS with demonstration of HHV-6 encoded small noncoding RNAs (sncRNAs) in Crohn's-like colitis: Case report.
A sulfasalazine-induced DRESS (Drug Reactivation with Eosinophilia and Systemic Symptoms) was complicated by a Crohn's-like colitis. We demonstra... | Recovered | ReactionOutcome | CC BY-NC-ND | 33598255 | 18,874,347 | 2021-02 |
What was the outcome of reaction 'Mononucleosis syndrome'? | Chronic persistent HHV-6B infection after sulfasalazine-induced DRESS with demonstration of HHV-6 encoded small noncoding RNAs (sncRNAs) in Crohn's-like colitis: Case report.
A sulfasalazine-induced DRESS (Drug Reactivation with Eosinophilia and Systemic Symptoms) was complicated by a Crohn's-like colitis. We demonstra... | Recovered | ReactionOutcome | CC BY-NC-ND | 33598255 | 18,874,347 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Febrile neutropenia'. | Toxic epidermal necrolysis associated with nivolumab treatment for head and neck cancer.
This report is the first to document TEN caused by nivolumab treatment in head and neck cancer. We believe this article can contribute significantly in understanding the principles of nivolumab treatment in patients with head and n... | CISPLATIN, FLUOROURACIL | DrugsGivenReaction | CC BY-NC | 33598257 | 19,034,916 | 2021-02 |
What was the dosage of drug 'CISPLATIN'? | Toxic epidermal necrolysis associated with nivolumab treatment for head and neck cancer.
This report is the first to document TEN caused by nivolumab treatment in head and neck cancer. We believe this article can contribute significantly in understanding the principles of nivolumab treatment in patients with head and n... | A REDUCED DOSAGE WAS USED | DrugDosageText | CC BY-NC | 33598257 | 19,034,916 | 2021-02 |
What was the dosage of drug 'FLUOROURACIL'? | Toxic epidermal necrolysis associated with nivolumab treatment for head and neck cancer.
This report is the first to document TEN caused by nivolumab treatment in head and neck cancer. We believe this article can contribute significantly in understanding the principles of nivolumab treatment in patients with head and n... | A REDUCED DOSAGE WAS USED | DrugDosageText | CC BY-NC | 33598257 | 19,034,916 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute kidney injury'. | Cryptococcemia in a patient with COVID-19: A case report.
The authors urge clinicians to balance the use of Immunosuppressant drugs and tocilizumab for COVID-19 patients to avoid the development of infections like Cryptococcemia, leading to death within 30 days.
1 BACKGROUND
Cryptococcus neoformans infection is a know... | HYDROCORTISONE SODIUM SUCCINATE, METHYLPREDNISOLONE, TOCILIZUMAB | DrugsGivenReaction | CC BY-NC-ND | 33598258 | 19,012,839 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastrointestinal haemorrhage'. | Cryptococcemia in a patient with COVID-19: A case report.
The authors urge clinicians to balance the use of Immunosuppressant drugs and tocilizumab for COVID-19 patients to avoid the development of infections like Cryptococcemia, leading to death within 30 days.
1 BACKGROUND
Cryptococcus neoformans infection is a know... | HYDROCORTISONE SODIUM SUCCINATE, METHYLPREDNISOLONE, TOCILIZUMAB | DrugsGivenReaction | CC BY-NC-ND | 33598258 | 19,012,839 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Cryptococcemia in a patient with COVID-19: A case report.
The authors urge clinicians to balance the use of Immunosuppressant drugs and tocilizumab for COVID-19 patients to avoid the development of infections like Cryptococcemia, leading to death within 30 days.
1 BACKGROUND
Cryptococcus neoformans infection is a know... | HYDROCORTISONE SODIUM SUCCINATE, METHYLPREDNISOLONE, TOCILIZUMAB | DrugsGivenReaction | CC BY-NC-ND | 33598258 | 19,012,839 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Cryptococcemia in a patient with COVID-19: A case report.
The authors urge clinicians to balance the use of Immunosuppressant drugs and tocilizumab for COVID-19 patients to avoid the development of infections like Cryptococcemia, leading to death within 30 days.
1 BACKGROUND
Cryptococcus neoformans infection is a know... | HYDROCORTISONE, METHYLPREDNISOLONE, TOCILIZUMAB | DrugsGivenReaction | CC BY-NC-ND | 33598258 | 19,029,149 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Systemic candida'. | Cryptococcemia in a patient with COVID-19: A case report.
The authors urge clinicians to balance the use of Immunosuppressant drugs and tocilizumab for COVID-19 patients to avoid the development of infections like Cryptococcemia, leading to death within 30 days.
1 BACKGROUND
Cryptococcus neoformans infection is a know... | HYDROCORTISONE, METHYLPREDNISOLONE, TOCILIZUMAB | DrugsGivenReaction | CC BY-NC-ND | 33598258 | 19,041,516 | 2021-02 |
What is the weight of the patient? | Cryptococcemia in a patient with COVID-19: A case report.
The authors urge clinicians to balance the use of Immunosuppressant drugs and tocilizumab for COVID-19 patients to avoid the development of infections like Cryptococcemia, leading to death within 30 days.
1 BACKGROUND
Cryptococcus neoformans infection is a know... | 72 kg. | Weight | CC BY-NC-ND | 33598258 | 19,029,149 | 2021-02 |
What was the dosage of drug 'METHYLPREDNISOLONE'? | Cryptococcemia in a patient with COVID-19: A case report.
The authors urge clinicians to balance the use of Immunosuppressant drugs and tocilizumab for COVID-19 patients to avoid the development of infections like Cryptococcemia, leading to death within 30 days.
1 BACKGROUND
Cryptococcus neoformans infection is a know... | RECEIVED SEVERAL DOSES | DrugDosageText | CC BY-NC-ND | 33598258 | 19,029,149 | 2021-02 |
What was the outcome of reaction 'Acute kidney injury'? | Cryptococcemia in a patient with COVID-19: A case report.
The authors urge clinicians to balance the use of Immunosuppressant drugs and tocilizumab for COVID-19 patients to avoid the development of infections like Cryptococcemia, leading to death within 30 days.
1 BACKGROUND
Cryptococcus neoformans infection is a know... | Not recovered | ReactionOutcome | CC BY-NC-ND | 33598258 | 19,012,839 | 2021-02 |
What was the outcome of reaction 'Candida infection'? | Cryptococcemia in a patient with COVID-19: A case report.
The authors urge clinicians to balance the use of Immunosuppressant drugs and tocilizumab for COVID-19 patients to avoid the development of infections like Cryptococcemia, leading to death within 30 days.
1 BACKGROUND
Cryptococcus neoformans infection is a know... | Recovered | ReactionOutcome | CC BY-NC-ND | 33598258 | 19,012,839 | 2021-02 |
What was the outcome of reaction 'Cryptococcosis'? | Cryptococcemia in a patient with COVID-19: A case report.
The authors urge clinicians to balance the use of Immunosuppressant drugs and tocilizumab for COVID-19 patients to avoid the development of infections like Cryptococcemia, leading to death within 30 days.
1 BACKGROUND
Cryptococcus neoformans infection is a know... | Fatal | ReactionOutcome | CC BY-NC-ND | 33598258 | 19,041,516 | 2021-02 |
What was the outcome of reaction 'Gastrointestinal haemorrhage'? | Cryptococcemia in a patient with COVID-19: A case report.
The authors urge clinicians to balance the use of Immunosuppressant drugs and tocilizumab for COVID-19 patients to avoid the development of infections like Cryptococcemia, leading to death within 30 days.
1 BACKGROUND
Cryptococcus neoformans infection is a know... | Recovered | ReactionOutcome | CC BY-NC-ND | 33598258 | 19,012,839 | 2021-02 |
What was the outcome of reaction 'Sepsis'? | Cryptococcemia in a patient with COVID-19: A case report.
The authors urge clinicians to balance the use of Immunosuppressant drugs and tocilizumab for COVID-19 patients to avoid the development of infections like Cryptococcemia, leading to death within 30 days.
1 BACKGROUND
Cryptococcus neoformans infection is a know... | Fatal | ReactionOutcome | CC BY-NC-ND | 33598258 | 19,041,516 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ascites'. | Severe tumor lysis syndrome during the induction therapy for the treatment of blastic plasmacytoid dendritic cell neoplasm arising from myelodysplastic/myeloproliferative neoplasms.
BPDCN shows clinically heterogeneous characteristics. And as other hematological malignancies, symptoms of BPDCN suggesting a high tumor b... | ASPARAGINASE, DEXAMETHASONE, ETOPOSIDE, FEBUXOSTAT, IFOSFAMIDE | DrugsGivenReaction | CC BY | 33598264 | 19,587,477 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Severe tumor lysis syndrome during the induction therapy for the treatment of blastic plasmacytoid dendritic cell neoplasm arising from myelodysplastic/myeloproliferative neoplasms.
BPDCN shows clinically heterogeneous characteristics. And as other hematological malignancies, symptoms of BPDCN suggesting a high tumor b... | ASPARAGINASE, DEXAMETHASONE, ETOPOSIDE, IFOSFAMIDE | DrugsGivenReaction | CC BY | 33598264 | 19,029,947 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pulmonary alveolar haemorrhage'. | Severe tumor lysis syndrome during the induction therapy for the treatment of blastic plasmacytoid dendritic cell neoplasm arising from myelodysplastic/myeloproliferative neoplasms.
BPDCN shows clinically heterogeneous characteristics. And as other hematological malignancies, symptoms of BPDCN suggesting a high tumor b... | ASPARAGINASE, DEXAMETHASONE, ETOPOSIDE, FEBUXOSTAT, IFOSFAMIDE | DrugsGivenReaction | CC BY | 33598264 | 19,587,477 | 2021-02 |
What was the outcome of reaction 'Ascites'? | Severe tumor lysis syndrome during the induction therapy for the treatment of blastic plasmacytoid dendritic cell neoplasm arising from myelodysplastic/myeloproliferative neoplasms.
BPDCN shows clinically heterogeneous characteristics. And as other hematological malignancies, symptoms of BPDCN suggesting a high tumor b... | Fatal | ReactionOutcome | CC BY | 33598264 | 19,587,477 | 2021-02 |
What was the outcome of reaction 'Circulatory collapse'? | Severe tumor lysis syndrome during the induction therapy for the treatment of blastic plasmacytoid dendritic cell neoplasm arising from myelodysplastic/myeloproliferative neoplasms.
BPDCN shows clinically heterogeneous characteristics. And as other hematological malignancies, symptoms of BPDCN suggesting a high tumor b... | Fatal | ReactionOutcome | CC BY | 33598264 | 19,587,477 | 2021-02 |
What was the outcome of reaction 'Drug ineffective'? | Severe tumor lysis syndrome during the induction therapy for the treatment of blastic plasmacytoid dendritic cell neoplasm arising from myelodysplastic/myeloproliferative neoplasms.
BPDCN shows clinically heterogeneous characteristics. And as other hematological malignancies, symptoms of BPDCN suggesting a high tumor b... | Fatal | ReactionOutcome | CC BY | 33598264 | 19,076,406 | 2021-02 |
What was the outcome of reaction 'Metabolic acidosis'? | Severe tumor lysis syndrome during the induction therapy for the treatment of blastic plasmacytoid dendritic cell neoplasm arising from myelodysplastic/myeloproliferative neoplasms.
BPDCN shows clinically heterogeneous characteristics. And as other hematological malignancies, symptoms of BPDCN suggesting a high tumor b... | Fatal | ReactionOutcome | CC BY | 33598264 | 19,587,477 | 2021-02 |
What was the outcome of reaction 'Pulmonary alveolar haemorrhage'? | Severe tumor lysis syndrome during the induction therapy for the treatment of blastic plasmacytoid dendritic cell neoplasm arising from myelodysplastic/myeloproliferative neoplasms.
BPDCN shows clinically heterogeneous characteristics. And as other hematological malignancies, symptoms of BPDCN suggesting a high tumor b... | Fatal | ReactionOutcome | CC BY | 33598264 | 19,587,477 | 2021-02 |
What was the outcome of reaction 'Tumour lysis syndrome'? | Severe tumor lysis syndrome during the induction therapy for the treatment of blastic plasmacytoid dendritic cell neoplasm arising from myelodysplastic/myeloproliferative neoplasms.
BPDCN shows clinically heterogeneous characteristics. And as other hematological malignancies, symptoms of BPDCN suggesting a high tumor b... | Fatal | ReactionOutcome | CC BY | 33598264 | 19,587,477 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug resistance'. | Treatment of genital herpes using olive leaf extract.
Genital herpes is one of the sexually transmitted diseases that is reported with a greater incidence of primary and secondary recurrence. In this study, olive leaf extract was used for its antiviral properties to treat the infection. The randomized-clinical trials u... | ACYCLOVIR | DrugsGivenReaction | CC BY-NC-ND | 33598284 | 18,955,420 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pathogen resistance'. | Treatment of genital herpes using olive leaf extract.
Genital herpes is one of the sexually transmitted diseases that is reported with a greater incidence of primary and secondary recurrence. In this study, olive leaf extract was used for its antiviral properties to treat the infection. The randomized-clinical trials u... | ACYCLOVIR | DrugsGivenReaction | CC BY-NC-ND | 33598284 | 18,955,420 | 2021-02 |
What was the outcome of reaction 'Drug resistance'? | Treatment of genital herpes using olive leaf extract.
Genital herpes is one of the sexually transmitted diseases that is reported with a greater incidence of primary and secondary recurrence. In this study, olive leaf extract was used for its antiviral properties to treat the infection. The randomized-clinical trials u... | Recovered | ReactionOutcome | CC BY-NC-ND | 33598284 | 18,955,420 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypoxia'. | Everolimus induced organizing pneumonia in a patient with tuberous sclerosis complex.
Organizing pneumonia is characterized by a distinct histologic pattern in the lung interstitium and presents clinically as hypoxemia, fever, cough, and dyspnea that is not attributable to concurrent infection. Typical etiologies of th... | EVEROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 33598397 | 19,548,885 | 2021 |
What was the dosage of drug 'AMOXICILLIN\CLAVULANATE POTASSIUM'? | Everolimus induced organizing pneumonia in a patient with tuberous sclerosis complex.
Organizing pneumonia is characterized by a distinct histologic pattern in the lung interstitium and presents clinically as hypoxemia, fever, cough, and dyspnea that is not attributable to concurrent infection. Typical etiologies of th... | UNKNOWN | DrugDosageText | CC BY-NC-ND | 33598397 | 19,015,144 | 2021 |
What was the dosage of drug 'AZITHROMYCIN ANHYDROUS'? | Everolimus induced organizing pneumonia in a patient with tuberous sclerosis complex.
Organizing pneumonia is characterized by a distinct histologic pattern in the lung interstitium and presents clinically as hypoxemia, fever, cough, and dyspnea that is not attributable to concurrent infection. Typical etiologies of th... | UNKNOWN | DrugDosageText | CC BY-NC-ND | 33598397 | 19,015,144 | 2021 |
What was the dosage of drug 'DOXYCYCLINE'? | Everolimus induced organizing pneumonia in a patient with tuberous sclerosis complex.
Organizing pneumonia is characterized by a distinct histologic pattern in the lung interstitium and presents clinically as hypoxemia, fever, cough, and dyspnea that is not attributable to concurrent infection. Typical etiologies of th... | UNKNOWN | DrugDosageText | CC BY-NC-ND | 33598397 | 19,015,144 | 2021 |
What was the outcome of reaction 'Hypoxia'? | Everolimus induced organizing pneumonia in a patient with tuberous sclerosis complex.
Organizing pneumonia is characterized by a distinct histologic pattern in the lung interstitium and presents clinically as hypoxemia, fever, cough, and dyspnea that is not attributable to concurrent infection. Typical etiologies of th... | Recovered | ReactionOutcome | CC BY-NC-ND | 33598397 | 19,548,885 | 2021 |
What was the outcome of reaction 'Organising pneumonia'? | Everolimus induced organizing pneumonia in a patient with tuberous sclerosis complex.
Organizing pneumonia is characterized by a distinct histologic pattern in the lung interstitium and presents clinically as hypoxemia, fever, cough, and dyspnea that is not attributable to concurrent infection. Typical etiologies of th... | Recovered | ReactionOutcome | CC BY-NC-ND | 33598397 | 19,015,144 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Secondary organizing pneumonia after coronavirus disease 2019: Two cases.
Coronavirus disease 2019 (COVID-19) has been reported to induce persistent symptoms even after an acute phase. However, the pathophysiology and treatment of this condition have been unclear. We report two patients who recovered from COVID-19, but... | DEXAMETHASONE, FAVIPIRAVIR | DrugsGivenReaction | CC BY-NC-ND | 33598398 | 19,253,264 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapeutic product effect incomplete'. | Secondary organizing pneumonia after coronavirus disease 2019: Two cases.
Coronavirus disease 2019 (COVID-19) has been reported to induce persistent symptoms even after an acute phase. However, the pathophysiology and treatment of this condition have been unclear. We report two patients who recovered from COVID-19, but... | DEXAMETHASONE, FAVIPIRAVIR | DrugsGivenReaction | CC BY-NC-ND | 33598398 | 19,254,957 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Aphasia'. | Successful implementation of classical ketogenic dietary therapy in a patient with Niemann-Pick disease type C.
Niemann-Pick disease type C (NP-C) is a neurodegenerative disease for which only palliative treatment exists, and only miglustat is effective in stabilizing neurological manifestations of NP-C. Ketogenic diet... | CLOBAZAM, LEVETIRACETAM, MIDAZOLAM, MIGLUSTAT | DrugsGivenReaction | CC BY-NC-ND | 33598405 | 19,465,164 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Constipation'. | Successful implementation of classical ketogenic dietary therapy in a patient with Niemann-Pick disease type C.
Niemann-Pick disease type C (NP-C) is a neurodegenerative disease for which only palliative treatment exists, and only miglustat is effective in stabilizing neurological manifestations of NP-C. Ketogenic diet... | CLOBAZAM, LEVETIRACETAM, MIDAZOLAM, MIGLUSTAT | DrugsGivenReaction | CC BY-NC-ND | 33598405 | 19,465,164 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diarrhoea'. | Successful implementation of classical ketogenic dietary therapy in a patient with Niemann-Pick disease type C.
Niemann-Pick disease type C (NP-C) is a neurodegenerative disease for which only palliative treatment exists, and only miglustat is effective in stabilizing neurological manifestations of NP-C. Ketogenic diet... | CLOBAZAM, LEVETIRACETAM, MIDAZOLAM, MIGLUSTAT | DrugsGivenReaction | CC BY-NC-ND | 33598405 | 19,465,164 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Multiple-drug resistance'. | Successful implementation of classical ketogenic dietary therapy in a patient with Niemann-Pick disease type C.
Niemann-Pick disease type C (NP-C) is a neurodegenerative disease for which only palliative treatment exists, and only miglustat is effective in stabilizing neurological manifestations of NP-C. Ketogenic diet... | CLOBAZAM, LEVETIRACETAM, MIDAZOLAM, MIGLUSTAT | DrugsGivenReaction | CC BY-NC-ND | 33598405 | 19,465,164 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Seizure'. | Successful implementation of classical ketogenic dietary therapy in a patient with Niemann-Pick disease type C.
Niemann-Pick disease type C (NP-C) is a neurodegenerative disease for which only palliative treatment exists, and only miglustat is effective in stabilizing neurological manifestations of NP-C. Ketogenic diet... | CLOBAZAM, LEVETIRACETAM, MIDAZOLAM, MIGLUSTAT | DrugsGivenReaction | CC BY-NC-ND | 33598405 | 19,465,164 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vomiting'. | Successful implementation of classical ketogenic dietary therapy in a patient with Niemann-Pick disease type C.
Niemann-Pick disease type C (NP-C) is a neurodegenerative disease for which only palliative treatment exists, and only miglustat is effective in stabilizing neurological manifestations of NP-C. Ketogenic diet... | CLOBAZAM, LEVETIRACETAM, MIDAZOLAM, MIGLUSTAT | DrugsGivenReaction | CC BY-NC-ND | 33598405 | 19,465,164 | 2021-06 |
What was the administration route of drug 'MIDAZOLAM'? | Successful implementation of classical ketogenic dietary therapy in a patient with Niemann-Pick disease type C.
Niemann-Pick disease type C (NP-C) is a neurodegenerative disease for which only palliative treatment exists, and only miglustat is effective in stabilizing neurological manifestations of NP-C. Ketogenic diet... | Buccal | DrugAdministrationRoute | CC BY-NC-ND | 33598405 | 19,465,164 | 2021-06 |
What was the dosage of drug 'CLOBAZAM'? | Successful implementation of classical ketogenic dietary therapy in a patient with Niemann-Pick disease type C.
Niemann-Pick disease type C (NP-C) is a neurodegenerative disease for which only palliative treatment exists, and only miglustat is effective in stabilizing neurological manifestations of NP-C. Ketogenic diet... | 0.15 MILLIGRAM/KILOGRAM/DAY | DrugDosageText | CC BY-NC-ND | 33598405 | 19,465,164 | 2021-06 |
What was the dosage of drug 'MIDAZOLAM'? | Successful implementation of classical ketogenic dietary therapy in a patient with Niemann-Pick disease type C.
Niemann-Pick disease type C (NP-C) is a neurodegenerative disease for which only palliative treatment exists, and only miglustat is effective in stabilizing neurological manifestations of NP-C. Ketogenic diet... | 10 MILLIGRAM | DrugDosageText | CC BY-NC-ND | 33598405 | 19,465,164 | 2021-06 |
What was the dosage of drug 'MIGLUSTAT'? | Successful implementation of classical ketogenic dietary therapy in a patient with Niemann-Pick disease type C.
Niemann-Pick disease type C (NP-C) is a neurodegenerative disease for which only palliative treatment exists, and only miglustat is effective in stabilizing neurological manifestations of NP-C. Ketogenic diet... | 400 MG/M2 | DrugDosageText | CC BY-NC-ND | 33598405 | 19,465,164 | 2021-06 |
What was the outcome of reaction 'Seizure'? | Successful implementation of classical ketogenic dietary therapy in a patient with Niemann-Pick disease type C.
Niemann-Pick disease type C (NP-C) is a neurodegenerative disease for which only palliative treatment exists, and only miglustat is effective in stabilizing neurological manifestations of NP-C. Ketogenic diet... | Recovering | ReactionOutcome | CC BY-NC-ND | 33598405 | 19,465,164 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Prostatic artery embolization for bladder outlet obstruction in the setting of prior posterior urethroplasty.
This case presents a patient with a remote history of complex posterior urethral repair related to a prior motorcycle accident who presented to the urology clinic in urinary retention with associated lower urin... | FINASTERIDE, TAMSULOSIN | DrugsGivenReaction | CC BY-NC-ND | 33598406 | 18,980,748 | 2021-05 |
What was the administration route of drug 'FINASTERIDE'? | Prostatic artery embolization for bladder outlet obstruction in the setting of prior posterior urethroplasty.
This case presents a patient with a remote history of complex posterior urethral repair related to a prior motorcycle accident who presented to the urology clinic in urinary retention with associated lower urin... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33598406 | 18,980,748 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Abdominal pain'. | The addition of deep hyperthermia to gemcitabine-based chemoradiation may achieve enhanced survival in unresectable locally advanced adenocarcinoma of the pancreas.
Driven by the current unsatisfactory outcomes for patients with locally advanced pancreatic cancer (LAPC), a biologically intensified clinical protocol was... | FLUOROURACIL, GEMCITABINE, IRINOTECAN, LEUCOVORIN, OXALIPLATIN | DrugsGivenReaction | CC BY-NC-ND | 33598571 | 19,202,901 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastric ulcer'. | The addition of deep hyperthermia to gemcitabine-based chemoradiation may achieve enhanced survival in unresectable locally advanced adenocarcinoma of the pancreas.
Driven by the current unsatisfactory outcomes for patients with locally advanced pancreatic cancer (LAPC), a biologically intensified clinical protocol was... | FLUOROURACIL, GEMCITABINE, IRINOTECAN, LEUCOVORIN, OXALIPLATIN | DrugsGivenReaction | CC BY-NC-ND | 33598571 | 19,202,901 | 2021-03 |
What was the dosage of drug 'GEMCITABINE'? | The addition of deep hyperthermia to gemcitabine-based chemoradiation may achieve enhanced survival in unresectable locally advanced adenocarcinoma of the pancreas.
Driven by the current unsatisfactory outcomes for patients with locally advanced pancreatic cancer (LAPC), a biologically intensified clinical protocol was... | GEMCITABINE?BASED CHEMORADIATION | DrugDosageText | CC BY-NC-ND | 33598571 | 19,202,901 | 2021-03 |
What was the outcome of reaction 'Abdominal pain'? | The addition of deep hyperthermia to gemcitabine-based chemoradiation may achieve enhanced survival in unresectable locally advanced adenocarcinoma of the pancreas.
Driven by the current unsatisfactory outcomes for patients with locally advanced pancreatic cancer (LAPC), a biologically intensified clinical protocol was... | Recovered | ReactionOutcome | CC BY-NC-ND | 33598571 | 19,202,901 | 2021-03 |
What was the outcome of reaction 'Gastric ulcer'? | The addition of deep hyperthermia to gemcitabine-based chemoradiation may achieve enhanced survival in unresectable locally advanced adenocarcinoma of the pancreas.
Driven by the current unsatisfactory outcomes for patients with locally advanced pancreatic cancer (LAPC), a biologically intensified clinical protocol was... | Recovered | ReactionOutcome | CC BY-NC-ND | 33598571 | 19,202,901 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Aortitis'. | Granulocyte colony stimulating factor-associated aortitis evaluated via multiple imaging modalities including vascular echography: a case report.
Granulocyte colony stimulating factor (G-CSF) preparations are used for patients with granulocytopenia, especially to prevent febrile neutropenia. Arteritis has been recogniz... | CARBOPLATIN, FILGRASTIM, PACLITAXEL | DrugsGivenReaction | CC BY-NC | 33598604 | 20,059,561 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myelosuppression'. | Granulocyte colony stimulating factor-associated aortitis evaluated via multiple imaging modalities including vascular echography: a case report.
Granulocyte colony stimulating factor (G-CSF) preparations are used for patients with granulocytopenia, especially to prevent febrile neutropenia. Arteritis has been recogniz... | CARBOPLATIN, FILGRASTIM, PACLITAXEL | DrugsGivenReaction | CC BY-NC | 33598604 | 20,059,561 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Normocytic anaemia'. | Granulocyte colony stimulating factor-associated aortitis evaluated via multiple imaging modalities including vascular echography: a case report.
Granulocyte colony stimulating factor (G-CSF) preparations are used for patients with granulocytopenia, especially to prevent febrile neutropenia. Arteritis has been recogniz... | CARBOPLATIN, FILGRASTIM, PACLITAXEL | DrugsGivenReaction | CC BY-NC | 33598604 | 20,059,561 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Platelet count decreased'. | Granulocyte colony stimulating factor-associated aortitis evaluated via multiple imaging modalities including vascular echography: a case report.
Granulocyte colony stimulating factor (G-CSF) preparations are used for patients with granulocytopenia, especially to prevent febrile neutropenia. Arteritis has been recogniz... | CARBOPLATIN, FILGRASTIM, PACLITAXEL | DrugsGivenReaction | CC BY-NC | 33598604 | 20,059,561 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'White blood cell count decreased'. | Granulocyte colony stimulating factor-associated aortitis evaluated via multiple imaging modalities including vascular echography: a case report.
Granulocyte colony stimulating factor (G-CSF) preparations are used for patients with granulocytopenia, especially to prevent febrile neutropenia. Arteritis has been recogniz... | CARBOPLATIN, FILGRASTIM, PACLITAXEL | DrugsGivenReaction | CC BY-NC | 33598604 | 20,059,561 | 2021-02 |
What was the dosage of drug 'CARBOPLATIN'? | Granulocyte colony stimulating factor-associated aortitis evaluated via multiple imaging modalities including vascular echography: a case report.
Granulocyte colony stimulating factor (G-CSF) preparations are used for patients with granulocytopenia, especially to prevent febrile neutropenia. Arteritis has been recogniz... | 583 MG (TARGET AREA UNDER THE CONCENTRATION- TIME CURVE 6 MG MIN/ML) | DrugDosageText | CC BY-NC | 33598604 | 20,059,561 | 2021-02 |
What was the outcome of reaction 'Aortitis'? | Granulocyte colony stimulating factor-associated aortitis evaluated via multiple imaging modalities including vascular echography: a case report.
Granulocyte colony stimulating factor (G-CSF) preparations are used for patients with granulocytopenia, especially to prevent febrile neutropenia. Arteritis has been recogniz... | Recovered | ReactionOutcome | CC BY-NC | 33598604 | 20,059,561 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiac ventricular thrombosis'. | 'The bubble heart': an unusual natural history told by multimodality imaging- a case report.
Intracardiac thrombosis is a relatively common pathological condition. Often, it is diagnosed at echocardiography during the subacute or chronic phase. In the very acute phase, tissue composition can make thrombus appearance ve... | FUROSEMIDE, SPIRONOLACTONE | DrugsGivenReaction | CC BY-NC | 33598615 | 20,050,868 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | 'The bubble heart': an unusual natural history told by multimodality imaging- a case report.
Intracardiac thrombosis is a relatively common pathological condition. Often, it is diagnosed at echocardiography during the subacute or chronic phase. In the very acute phase, tissue composition can make thrombus appearance ve... | AMIODARONE, BISOPROLOL, FUROSEMIDE, HEPARIN SODIUM, MAGNESIUM SULFATE, RAMIPRIL, SPIRONOLACTONE, WARFARIN | DrugsGivenReaction | CC BY-NC | 33598615 | 20,050,010 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemoconcentration'. | 'The bubble heart': an unusual natural history told by multimodality imaging- a case report.
Intracardiac thrombosis is a relatively common pathological condition. Often, it is diagnosed at echocardiography during the subacute or chronic phase. In the very acute phase, tissue composition can make thrombus appearance ve... | FUROSEMIDE, SPIRONOLACTONE | DrugsGivenReaction | CC BY-NC | 33598615 | 20,050,868 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ventricular dysfunction'. | 'The bubble heart': an unusual natural history told by multimodality imaging- a case report.
Intracardiac thrombosis is a relatively common pathological condition. Often, it is diagnosed at echocardiography during the subacute or chronic phase. In the very acute phase, tissue composition can make thrombus appearance ve... | FUROSEMIDE, SPIRONOLACTONE | DrugsGivenReaction | CC BY-NC | 33598615 | 20,050,868 | 2021-02 |
What was the administration route of drug 'AMIODARONE'? | 'The bubble heart': an unusual natural history told by multimodality imaging- a case report.
Intracardiac thrombosis is a relatively common pathological condition. Often, it is diagnosed at echocardiography during the subacute or chronic phase. In the very acute phase, tissue composition can make thrombus appearance ve... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33598615 | 20,050,010 | 2021-02 |
What was the administration route of drug 'HEPARIN SODIUM'? | 'The bubble heart': an unusual natural history told by multimodality imaging- a case report.
Intracardiac thrombosis is a relatively common pathological condition. Often, it is diagnosed at echocardiography during the subacute or chronic phase. In the very acute phase, tissue composition can make thrombus appearance ve... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33598615 | 20,050,010 | 2021-02 |
What was the administration route of drug 'MAGNESIUM SULFATE'? | 'The bubble heart': an unusual natural history told by multimodality imaging- a case report.
Intracardiac thrombosis is a relatively common pathological condition. Often, it is diagnosed at echocardiography during the subacute or chronic phase. In the very acute phase, tissue composition can make thrombus appearance ve... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33598615 | 20,050,010 | 2021-02 |
What was the administration route of drug 'SPIRONOLACTONE'? | 'The bubble heart': an unusual natural history told by multimodality imaging- a case report.
Intracardiac thrombosis is a relatively common pathological condition. Often, it is diagnosed at echocardiography during the subacute or chronic phase. In the very acute phase, tissue composition can make thrombus appearance ve... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33598615 | 20,039,449 | 2021-02 |
What was the dosage of drug 'HEPARIN SODIUM'? | 'The bubble heart': an unusual natural history told by multimodality imaging- a case report.
Intracardiac thrombosis is a relatively common pathological condition. Often, it is diagnosed at echocardiography during the subacute or chronic phase. In the very acute phase, tissue composition can make thrombus appearance ve... | INTRAVENOUS BOLUS OF 5000 UI FOLLOWED BY CONTINUOUS INFUSION OF 20000-40000 UI PER DAY | DrugDosageText | CC BY-NC | 33598615 | 20,050,010 | 2021-02 |
What was the outcome of reaction 'Cardiac ventricular thrombosis'? | 'The bubble heart': an unusual natural history told by multimodality imaging- a case report.
Intracardiac thrombosis is a relatively common pathological condition. Often, it is diagnosed at echocardiography during the subacute or chronic phase. In the very acute phase, tissue composition can make thrombus appearance ve... | Recovered | ReactionOutcome | CC BY-NC | 33598615 | 20,050,868 | 2021-02 |
What was the outcome of reaction 'Haemoconcentration'? | 'The bubble heart': an unusual natural history told by multimodality imaging- a case report.
Intracardiac thrombosis is a relatively common pathological condition. Often, it is diagnosed at echocardiography during the subacute or chronic phase. In the very acute phase, tissue composition can make thrombus appearance ve... | Recovered | ReactionOutcome | CC BY-NC | 33598615 | 20,050,868 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy non-responder'. | The characteristics and efficacy of catheter ablation of focal atrial tachycardia arising from an epicardial site.
BACKGROUND
Although epicardial structures around the atrium such as adipose tissue possess arrhythmogenicity, little is known about atrial tachycardias (ATs) originating from epicardial sites (Epi-ATs). Th... | BISOPROLOL, FLECAINIDE | DrugsGivenReaction | CC BY | 33598933 | 19,508,571 | 2021-04 |
What was the outcome of reaction 'Electrocardiogram QT prolonged'? | Impact of Medical Castration on Malignant Arrhythmias in Patients With Prostate Cancer.
Background Medical castration, gonadotropin-releasing hormone agonists, and antiandrogens have been widely applied as a treatment for prostate cancer. Sex steroid hormones influence cardiac ion channels. However, few studies have ex... | Recovering | ReactionOutcome | CC BY-NC-ND | 33599136 | 20,017,937 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Crohn^s disease'. | Successful treatment with vedolizumab in an adolescent with Crohn disease who had developed active pulmonary tuberculosis while receiving infliximab.
Vedolizumab (VDZ) has been approved for the treatment of inflammatory bowel diseases (IBDs) in patients aged ≥18 years. We report a case of a pediatric patient with Crohn... | AZATHIOPRINE, INFLIXIMAB, MESALAMINE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 33601494 | 18,963,545 | 2021-07 |
What was the administration route of drug 'INFLIXIMAB'? | Successful treatment with vedolizumab in an adolescent with Crohn disease who had developed active pulmonary tuberculosis while receiving infliximab.
Vedolizumab (VDZ) has been approved for the treatment of inflammatory bowel diseases (IBDs) in patients aged ≥18 years. We report a case of a pediatric patient with Crohn... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33601494 | 19,625,958 | 2021-07 |
What was the administration route of drug 'PREDNISOLONE'? | Successful treatment with vedolizumab in an adolescent with Crohn disease who had developed active pulmonary tuberculosis while receiving infliximab.
Vedolizumab (VDZ) has been approved for the treatment of inflammatory bowel diseases (IBDs) in patients aged ≥18 years. We report a case of a pediatric patient with Crohn... | Oral | DrugAdministrationRoute | CC BY-NC | 33601494 | 18,963,545 | 2021-07 |
What was the dosage of drug 'AZATHIOPRINE'? | Successful treatment with vedolizumab in an adolescent with Crohn disease who had developed active pulmonary tuberculosis while receiving infliximab.
Vedolizumab (VDZ) has been approved for the treatment of inflammatory bowel diseases (IBDs) in patients aged ≥18 years. We report a case of a pediatric patient with Crohn... | UNKNOWN | DrugDosageText | CC BY-NC | 33601494 | 18,963,545 | 2021-07 |
What was the dosage of drug 'INFLIXIMAB'? | Successful treatment with vedolizumab in an adolescent with Crohn disease who had developed active pulmonary tuberculosis while receiving infliximab.
Vedolizumab (VDZ) has been approved for the treatment of inflammatory bowel diseases (IBDs) in patients aged ≥18 years. We report a case of a pediatric patient with Crohn... | UNKNOWN | DrugDosageText | CC BY-NC | 33601494 | 18,963,545 | 2021-07 |
What was the dosage of drug 'MESALAMINE'? | Successful treatment with vedolizumab in an adolescent with Crohn disease who had developed active pulmonary tuberculosis while receiving infliximab.
Vedolizumab (VDZ) has been approved for the treatment of inflammatory bowel diseases (IBDs) in patients aged ≥18 years. We report a case of a pediatric patient with Crohn... | UNKNOWN | DrugDosageText | CC BY-NC | 33601494 | 18,963,545 | 2021-07 |
What was the dosage of drug 'PREDNISOLONE'? | Successful treatment with vedolizumab in an adolescent with Crohn disease who had developed active pulmonary tuberculosis while receiving infliximab.
Vedolizumab (VDZ) has been approved for the treatment of inflammatory bowel diseases (IBDs) in patients aged ≥18 years. We report a case of a pediatric patient with Crohn... | 50 mg (milligrams). | DrugDosage | CC BY-NC | 33601494 | 18,963,545 | 2021-07 |
What was the outcome of reaction 'Crohn^s disease'? | Successful treatment with vedolizumab in an adolescent with Crohn disease who had developed active pulmonary tuberculosis while receiving infliximab.
Vedolizumab (VDZ) has been approved for the treatment of inflammatory bowel diseases (IBDs) in patients aged ≥18 years. We report a case of a pediatric patient with Crohn... | Recovering | ReactionOutcome | CC BY-NC | 33601494 | 18,963,545 | 2021-07 |
What was the outcome of reaction 'Pulmonary tuberculosis'? | Successful treatment with vedolizumab in an adolescent with Crohn disease who had developed active pulmonary tuberculosis while receiving infliximab.
Vedolizumab (VDZ) has been approved for the treatment of inflammatory bowel diseases (IBDs) in patients aged ≥18 years. We report a case of a pediatric patient with Crohn... | Recovered | ReactionOutcome | CC BY-NC | 33601494 | 19,625,958 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Angiocentric lymphoma'. | Chronic lymphocytic infiltration with pontine perivascular enhancement responsive to steroids (CLIPPERS) and its association with Epstein-Barr Virus (EBV)-related lymphomatoid granulomatosis: a case report.
BACKGROUND
Chronic lymphocytic infiltration with pontine perivascular enhancement responsive to steroids (CLIPPER... | METHYLPREDNISOLONE, MYCOPHENOLATE MOFETIL, PREDNISOLONE | DrugsGivenReaction | CC BY | 33602163 | 19,840,581 | 2021-02-18 |
What was the administration route of drug 'PREDNISOLONE'? | Chronic lymphocytic infiltration with pontine perivascular enhancement responsive to steroids (CLIPPERS) and its association with Epstein-Barr Virus (EBV)-related lymphomatoid granulomatosis: a case report.
BACKGROUND
Chronic lymphocytic infiltration with pontine perivascular enhancement responsive to steroids (CLIPPER... | Oral | DrugAdministrationRoute | CC BY | 33602163 | 19,840,581 | 2021-02-18 |
What was the dosage of drug 'PREDNISOLONE'? | Chronic lymphocytic infiltration with pontine perivascular enhancement responsive to steroids (CLIPPERS) and its association with Epstein-Barr Virus (EBV)-related lymphomatoid granulomatosis: a case report.
BACKGROUND
Chronic lymphocytic infiltration with pontine perivascular enhancement responsive to steroids (CLIPPER... | DOWN TO 20 MG/DAY | DrugDosageText | CC BY | 33602163 | 19,840,581 | 2021-02-18 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood creatine phosphokinase increased'. | Catatonia associated with late-life psychosis successfully treated with lithium: a case report.
BACKGROUND
Catatonia is a psychomotor syndrome that presents various symptoms ranging from stupor to agitation, with prominent disturbances of volition. Its pathogenesis is poorly understood. Benzodiazepines and electroconvu... | BLONANSERIN, LITHIUM, LORAZEPAM, MIDAZOLAM | DrugsGivenReaction | CC BY | 33602282 | 19,733,655 | 2021-02-18 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Delirium'. | Catatonia associated with late-life psychosis successfully treated with lithium: a case report.
BACKGROUND
Catatonia is a psychomotor syndrome that presents various symptoms ranging from stupor to agitation, with prominent disturbances of volition. Its pathogenesis is poorly understood. Benzodiazepines and electroconvu... | LORAZEPAM | DrugsGivenReaction | CC BY | 33602282 | 19,742,073 | 2021-02-18 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Delusion'. | Catatonia associated with late-life psychosis successfully treated with lithium: a case report.
BACKGROUND
Catatonia is a psychomotor syndrome that presents various symptoms ranging from stupor to agitation, with prominent disturbances of volition. Its pathogenesis is poorly understood. Benzodiazepines and electroconvu... | BLONANSERIN, LITHIUM, LORAZEPAM, MIDAZOLAM | DrugsGivenReaction | CC BY | 33602282 | 19,733,655 | 2021-02-18 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hallucination'. | Catatonia associated with late-life psychosis successfully treated with lithium: a case report.
BACKGROUND
Catatonia is a psychomotor syndrome that presents various symptoms ranging from stupor to agitation, with prominent disturbances of volition. Its pathogenesis is poorly understood. Benzodiazepines and electroconvu... | BLONANSERIN, LITHIUM, LORAZEPAM, MIDAZOLAM | DrugsGivenReaction | CC BY | 33602282 | 19,733,655 | 2021-02-18 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.